The use of the inhibitor of KDM5B CPI-455 depleted the fraction of CD44+ and ALDH+ oral cancer stem cells and attenuated tumorsphere formation, while it did not affect cell viability or apoptosis. The gene discussed is KDM5B; the disease is lip and oral cavity carcinoma.